These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A novel CD8 T cell-restricted CD45RB epitope shared by CD43 is differentially affected by glycosylation. Carlow DA; Ardman B; Ziltener HJ J Immunol; 1999 Aug; 163(3):1441-8. PubMed ID: 10415045 [TBL] [Abstract][Full Text] [Related]
4. Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line. Lefebvre JC; Giordanengo V; Limouse M; Doglio A; Cucchiarini M; Monpoux F; Mariani R; Peyron JF J Exp Med; 1994 Nov; 180(5):1609-17. PubMed ID: 7964449 [TBL] [Abstract][Full Text] [Related]
5. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure. Hiserodt JC J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707 [TBL] [Abstract][Full Text] [Related]
6. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function. Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156 [TBL] [Abstract][Full Text] [Related]
7. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes. Fan J; Bonavida B J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189 [TBL] [Abstract][Full Text] [Related]
8. Autoantibodies directed against CD43 molecules with an altered glycosylation status on human immunodeficiency virus type 1 (HIV-1)-infected CEM cells are found in all HIV-1+ individuals. Giordanengo V; Limouse M; Desroys du Roure L; Cottalorda J; Doglio A; Passeron A; Fuzibet JG; Lefebvre JC Blood; 1995 Sep; 86(6):2302-11. PubMed ID: 7662977 [TBL] [Abstract][Full Text] [Related]
9. Antileukemia activity of a natural killer cell line against human leukemias. Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753 [TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein. de Laurentiis A; Gaspari M; Palmieri C; Falcone C; Iaccino E; Fiume G; Massa O; Masullo M; Tuccillo FM; Roveda L; Prati U; Fierro O; Cozzolino I; Troncone G; Tassone P; Scala G; Quinto I Mol Cell Proteomics; 2011 May; 10(5):M111.007898. PubMed ID: 21372249 [TBL] [Abstract][Full Text] [Related]
11. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state. Weinhold KJ; Wheelock EF Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603 [TBL] [Abstract][Full Text] [Related]
12. The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. Cyster JG; Shotton DM; Williams AF EMBO J; 1991 Apr; 10(4):893-902. PubMed ID: 1706994 [TBL] [Abstract][Full Text] [Related]
13. Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways. Yang S; Haluska FG J Immunol; 2004 Apr; 172(7):4599-608. PubMed ID: 15034078 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T cells reactive to an immunodominant leukemia-associated antigen can be specifically primed and expanded by combining a specific priming step with nonspecific large-scale expansion. Ghosh A; Wolenski M; Klein C; Welte K; Blazar BR; Sauer MG J Immunother; 2008; 31(2):121-31. PubMed ID: 18481382 [TBL] [Abstract][Full Text] [Related]
15. A Chemo-enzymatically Linked Bispecific Antibody Retargets T Cells to a Sialylated Epitope on CD43 in Acute Myeloid Leukemia. Bartels L; de Jong G; Gillissen MA; Yasuda E; Kattler V; Bru C; Fatmawati C; van Hal-van Veen SE; Cercel MG; Moiset G; Bakker AQ; van Helden PM; Villaudy J; Hazenberg MD; Spits H; Wagner K Cancer Res; 2019 Jul; 79(13):3372-3382. PubMed ID: 31064847 [TBL] [Abstract][Full Text] [Related]
16. An Immunocompetent Mouse Model for MLL/AF9 Leukemia Reveals the Potential of Spontaneous Cytotoxic T-Cell Response to an Antigen Expressed in Leukemia Cells. Hasegawa K; Tanaka S; Fujiki F; Morimoto S; Nakajima H; Tatsumi N; Nakata J; Takashima S; Nishida S; Tsuboi A; Oka Y; Oji Y; Kumanogoh A; Sugiyama H; Hosen N PLoS One; 2015; 10(12):e0144594. PubMed ID: 26658107 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the activation-associated isoform of CD43 on murine T lymphocytes. Jones AT; Federsppiel B; Ellies LG; Williams MJ; Burgener R; Duronio V; Smith CA; Takei F; Ziltener HJ J Immunol; 1994 Oct; 153(8):3426-39. PubMed ID: 7523493 [TBL] [Abstract][Full Text] [Related]
18. Selective binding of concanavalin A to target cell major histocompatibility antigens is required to induce nonspecific conjugation and lysis by cytolytic T lymphocytes in lectin-dependent cytotoxicity. Keren Z; Berke G Cell Immunol; 1984 Dec; 89(2):458-77. PubMed ID: 6334564 [TBL] [Abstract][Full Text] [Related]
19. Novel tumor-associated accessory molecules involved in the gamma/delta cytotoxic T-lymphocyte-Burkitt's lymphoma interaction. Nelson EL; Kim HT; Mar ND; Goralski TJ; McIntyre BW; Clayberger C; Krensky AM Cancer; 1995 Feb; 75(3):886-93. PubMed ID: 7530169 [TBL] [Abstract][Full Text] [Related]
20. Determination of cellularly processed HLA-A2402-restricted novel CTL epitopes derived from two cancer germ line genes, MAGE-A4 and SAGE. Miyahara Y; Naota H; Wang L; Hiasa A; Goto M; Watanabe M; Kitano S; Okumura S; Takemitsu T; Yuta A; Majima Y; Lemonnier FA; Boon T; Shiku H Clin Cancer Res; 2005 Aug; 11(15):5581-9. PubMed ID: 16061876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]